my account  log out
 

Buprenorphine(3), HRP-conjugated

Create: 07/26/2019
Expired Date:never
Category: Medical testing [Health&Medical&Pharmaceutical]
Message:Buprenorphine is a highly lipophylic derivative of the Thebaine and is a powerful partial agonist analgesic. It is effective in treating pain and is 25 to 40 times more potent than morphine. Since the 1980s it has been widely prescribed for the treatment of moderate to severe pain and in anaesthesiology for premedication and/or anaesthetic induction. Soon after buprenorphine became clinically available there were reports of abuse as it was frequently used as the drug of choice when there was a shortage of heroin supplies. Studies then showed that when buprenorphine was used for opiate dependence treatment the withdrawal syndrome on discontinuing buprenorphine was milder than methadone and that fewer symptoms emerged during detoxification with buprenorphine. Buprenorphine (C29 H41 NO4) is a prescription medication for people addicted to heroin or other opiates that acts by relieving the symptoms of opiate withdrawal such as agitation, nausea and insomnia. Buprenorphine is more weakly addictive and has a lower risk of overdose than methadone. The effects last for about three days. https://www.creative-diagnostics.com/Buprenorphine-3-HRP-conjugated-105633-219.htm
City:Shirley[US] 
Location:
 
Aug 27 2019Recombinant HCV core 24 genotype 1b496
Aug 27 2019Recombinant HCV core 2-119aa genotype 2499
Aug 27 2019Active hepatitis c virus Hepatitis C virus Genotype 1b NS3 protein512
Aug 27 2019Hepatitis C Virus Hepatitis C Virus NS4A protein481
Aug 27 2019Active Hepatitis C Virus Core 1a protein439
Aug 27 2019Hepatitis C Virus Hepatitis C Virus NS4 protein484
Aug 27 2019Hepatitis C Virus Hepatitis C Virus Core Antigen protein474
Aug 27 2019Hepatitis C Virus Hepatitis C Virus NS5a protein496
Aug 27 2019Active hepatitis c virus Hepatitis C Virus NS3 (mutated A156 T) protein485
Aug 27 2019Hepatitis C Virus Hepatitis C Virus protein464

return back

Copyright © toextrade Inc. All rights reserved. Contact us